These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 9397372)
1. Prescribing pattern of vancomycin in a community teaching hospital with low prevalence of vancomycin-resistant enterococci. Watanakunakorn C Infect Control Hosp Epidemiol; 1997 Nov; 18(11):767-9. PubMed ID: 9397372 [TBL] [Abstract][Full Text] [Related]
2. Vancomycin use in a university medical center: comparison with hospital infection control practices advisory committee guidelines. Evans ME; Kortas KJ Infect Control Hosp Epidemiol; 1996 Jun; 17(6):356-9. PubMed ID: 8805065 [TBL] [Abstract][Full Text] [Related]
3. Vancomycin use in a hospital with high prevalence of methicillin-resistant Staphylococcus aureus: comparison with Hospital Infection Control Practices Advisory Committe Guidelines (HICPAC). Melo DO; Sasaki M; Grinbaum RS Braz J Infect Dis; 2007 Feb; 11(1):53-6. PubMed ID: 17625728 [TBL] [Abstract][Full Text] [Related]
5. Vancomycin use in 2 Ontario tertiary care hospitals: a survey. Kwan T; Lin F; Ngai B; Loeb M Clin Invest Med; 1999 Dec; 22(6):256-64. PubMed ID: 10664867 [TBL] [Abstract][Full Text] [Related]
6. Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep; 1995 Sep; 44(RR-12):1-13. PubMed ID: 7565541 [TBL] [Abstract][Full Text] [Related]
7. Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). Am J Infect Control; 1995 Apr; 23(2):87-94. PubMed ID: 7639408 [TBL] [Abstract][Full Text] [Related]
8. Vancomycin use in a university medical center: effect of a vancomycin continuation form. Evans ME; Millheim ET; Rapp RP Infect Control Hosp Epidemiol; 1999 Jun; 20(6):417-20. PubMed ID: 10395144 [TBL] [Abstract][Full Text] [Related]
9. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: therapeutic realities and possibilities. Michel M; Gutmann L Lancet; 1997 Jun; 349(9069):1901-6. PubMed ID: 9217771 [TBL] [Abstract][Full Text] [Related]
10. Enemy within. Basic weapons can foil VRE (vancomycin-resistant enterococcus). Pugliese G Mater Manag Health Care; 1997 Sep; 6(9):32, 34, 36-8. PubMed ID: 10173223 [No Abstract] [Full Text] [Related]
12. Spread of vancomycin-resistant enterococci: why did it happen in the United States? Martone WJ Infect Control Hosp Epidemiol; 1998 Aug; 19(8):539-45. PubMed ID: 9758052 [TBL] [Abstract][Full Text] [Related]
13. A clinical decision process model for evaluating vancomycin use with modified HICPAC guidelines. Hospital Infection Control Practice Advisory Committee. Salemi C; Becker L; Morrissey R; Warmington J Clin Perform Qual Health Care; 1998; 6(1):12-6. PubMed ID: 10177043 [TBL] [Abstract][Full Text] [Related]
14. Control of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus in hospitalized children. Fisher MC Pediatr Infect Dis J; 1998 Sep; 17(9):825-6. PubMed ID: 9779772 [No Abstract] [Full Text] [Related]
15. Characteristics of a large cluster of vancomycin-resistant enterococci in an Australian hospital. Cooper E; Paull A; O'Reilly M Infect Control Hosp Epidemiol; 2002 Mar; 23(3):151-3. PubMed ID: 11918122 [TBL] [Abstract][Full Text] [Related]
16. Vancomycin use in a Brazilian teaching hospital: comparison with the Hospital Infection Controlpractices Advisory Committee Guidelines (HICPAC). Melo DO; Ribeiro E Braz J Infect Dis; 2009 Jun; 13(3):161-4. PubMed ID: 20191189 [TBL] [Abstract][Full Text] [Related]